EDECRIN 25 MG
ETHACRYNIC ACID : 25 MG · DIN 02258528 · BAUSCH HEALTH, CANADA INC.
Health Canada status: MARKETED
What is EDECRIN?
EDECRIN 25 MG contains ETHACRYNIC ACID : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 02258528, held by BAUSCH HEALTH, CANADA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 22-Dec-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02258528 |
|---|---|
| Brand name | EDECRIN |
| Generic / active ingredient | ETHACRYNIC ACID : 25 MG |
| Manufacturer | BAUSCH HEALTH, CANADA INC. |
| Strength | 25 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C03CC01 ETACRYNIC ACID |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 22-Dec-2020 |
What can be used instead?
Other Canadian products sharing ATC code C03CC01 ETACRYNIC ACID. 2 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ETHACRYNATE SODIUM | 50 MG | POWDER FOR SOLUTION | STERIMAX INC | MARKETED | DIN 02462362 |
| EDECRIN TAB 50MG | 50 MG | TABLET | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | DIN 00016497 |
| ETHACRYNATE SODIUM FOR INJECTION | 50 MG | POWDER FOR SOLUTION | ENDO PAR INNOVATION COMPANY, LLC | CANCELLED PRE MARKET | DIN 02479591 |
| ETHACRYNATE SODIUM FOR INJECTION USP | 50 MG | POWDER FOR SOLUTION | STERIMAX INC | DORMANT | DIN 02469456 |
| SODIUM EDECRIN | 50 MG | POWDER FOR SOLUTION | BAUSCH HEALTH, CANADA INC. | DORMANT | DIN 00268313 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.